Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 18, 2023

SELL
$122.0 - $145.31 $736,758 - $877,527
-6,039 Reduced 24.01%
19,114 $2.47 Million
Q1 2023

May 10, 2023

BUY
$133.98 - $160.47 $144,296 - $172,826
1,077 Added 4.47%
25,153 $3.68 Million
Q4 2022

Feb 08, 2023

BUY
$129.72 - $159.85 $155,274 - $191,340
1,197 Added 5.23%
24,076 $3.84 Million
Q3 2022

Oct 26, 2022

SELL
$126.59 - $161.18 $2.67 Million - $3.4 Million
-21,079 Reduced 47.95%
22,879 $3.05 Million
Q2 2022

Aug 03, 2022

BUY
$141.59 - $168.66 $298,471 - $355,535
2,108 Added 5.04%
43,958 $6.86 Million
Q1 2022

Apr 28, 2022

SELL
$129.64 - $160.7 $2.18 Million - $2.7 Million
-16,812 Reduced 28.66%
41,850 $6.52 Million
Q4 2021

Feb 02, 2022

BUY
$119.87 - $145.67 $736,481 - $894,996
6,144 Added 11.7%
58,662 $7.47 Million
Q3 2021

Oct 27, 2021

BUY
$128.64 - $184.79 $6.76 Million - $9.7 Million
52,518 New
52,518 $6.84 Million

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.63B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Iq Eq Fund Management (Ireland) LTD Portfolio

Follow Iq Eq Fund Management (Ireland) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Iq Eq Fund Management (Ireland) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Iq Eq Fund Management (Ireland) LTD with notifications on news.